International drug giant GSK plc is moving its vaccine R&D and infectious disease teams to Cambridge from Maryland, and plans ...

PHOENIX — Arizona is suing a major drug maker, accusing it of gaming the system by simply renaming an asthma drug to allow it ...

Since 1999, Feb. 7 has marked National Black HIV/AIDS Awareness Day, drawing attention to the disproportionate impact of HIV ...

The stock market was up and down with Trump tariff fears in focus. Palantir led big earnings winners. Google and Amazon were ...

Arizona is suing a major drug maker, accusing it of gaming the system by simply renaming an asthma drug to allow it to ...

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased GSK plc. ("GSK" or the "Company") (NYSE: GSK) American Depositary Receipts ...

GSK PLC GSK shares slid 2.47% to £14.43 Friday, on what proved to be an all-around dismal trading session for the stock ...

Harvey Jones is looking to build a balanced portfolio of UK shares to fund his final years, and asked ChatGPT to recommend a ...

Among them, the cardiac, anti-diabetic, and gastrointestinal therapies saw high value growth of 10.9 per cent, 10.2 per cent, and 6.9 per cent, respectively, driving overall IPM growth ...

Arizona Attorney General Kris Mayes on Thursday sued pharmaceutical manufacturer GlaxoSmithKline for engaging in deceptive and unfair practices ...

GSK's oncology sales increased 98% in 2024, and reflects strong demand and potentially new launches or indications for cancer therapies.

Deals, pipeline updates and geopolitical issues drove the conversation at the 2025 JP Morgan Healthcare conference.